Recently, our group identified exportin 1, a nuclear exporter, as a promising therapeutic target in NE tumors, including SCLC and NEPC.226,227 Exportin 1 was found to be upregulated during the very early stages of NE transformation, immediately following TP53 and RB1 inactivation. The gene discussed is RB1; the disease is small cell lung carcinoma.